Company Search:
Advanced Search
Sponsored Links
Anhui Fengyuan Pharmaceutical Company Snapshot
Anhui Fengyuan Pharmaceutical operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Anhui Fengyuan Pharmaceutical with three other companies in this sector in CHINA : Jiuzhitang Company Limited (2019 sales of 3.18 billion Chinese Renmimbi [US$458.36 million] of which 88% was Pharmacuetical Industry), Chengdu Kanghong Pharmaceutical Group Co Ltd (3.26 billion Chinese Renmimbi [US$468.94 million] of which 100% was Pharmaceutical Manufacturing), and Heilongjiang ZBD Pharmaceutical Co Ltd (3.29 billion Chinese Renmimbi [US$473.92 million] of which 62% was Pharmaceutical Industry).

Sales Analysis. During the year ended December of 2019, sales at Anhui Fengyuan Pharmaceutical were 3.24 billion Chinese Renmimbi (US$466.18 million). This is an increase of 7.5% versus 2018, when the company's sales were 3.01 billion Chinese Renmimbi. This was the fourth straight year of sales growth at Anhui Fengyuan Pharmaceutical. Sales of Medicine Retail Circulation saw an increase that was more than double the company's growth rate: sales were up 18.2% in 2019, from 1.29 billion Chinese Renmimbi to 1.53 billion Chinese Renmimbi. Anhui Fengyuan Pharmaceutical also saw significant increases in sales in Other Operations (up 11.1% to 62.93 million Chinese Renmimbi) . Not all segments of Anhui Fengyuan Pharmaceutical experienced an increase in sales in 2019: sales of Medicine Manufacturing fell 1.1% to 1.65 billion Chinese Renmimbi.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Anhui Fengyuan Pharmaceutical
  Stock Performance Chart for Anhui Fengyuan Pharmaceutical
  Stock Data: Recent Stock Performance:
  Current Price (8/7/2020): 12.45
(Figures in Chinese Renmimbi)
1 Week -4.4%   13 Weeks 48.2%  
4 Weeks 53.1%   52 Weeks 118.0%  
Anhui Fengyuan Pharmaceutical Key Data:
  Ticker: 000153 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 3,238,064,437
(Year Ending Jan 2020).
Employees: 4,668
  Currency: Chinese Renmimbi Market Cap: 3,886,158,314
  Fiscal Yr Ends: December Shares Outstanding: 312,141,230
  Share Type: A Gu Closely Held Shares: 106,204,508
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.